blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3138855

EP3138855 - ACTIVATED SIALIC ACID DERIVATIVES FOR PROTEIN DERIVATISATION AND CONJUGATION [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  20.12.2019
Database last updated on 31.08.2024
FormerGrant of patent is intended
Status updated on  17.03.2019
FormerRequest for examination was made
Status updated on  15.09.2017
FormerThe application has been published
Status updated on  03.02.2017
Most recent event   Tooltip20.12.2019Application deemed to be withdrawnpublished on 22.01.2020  [2020/04]
Applicant(s)For all designated states
Lipoxen Technologies Limited
London BioScience Innovation Centre 2 Royal College Street
London NW1 0NH / GB
[2017/10]
Inventor(s)01 / JAIN, Sanjay
Lipoxen Technologies Limited
London Bioscience Innovation Centre
2 Royal College Street
London, NW1 0NH / GB
02 / PAPAIOANNOU, Ioannis
Lipoxen Technologies Limited
London Bioscience Innovation Centre
2 Royal College Street
London, NW1 0NH / GB
03 / THOBHANI, Smita
Lipoxen Technologies Limited
London Bioscience Innovation Centre
2 Royal College Street
London, NW1 0NH / GB
 [2017/10]
Representative(s)Icosa, et al
83 avenue Denfert-Rochereau
75014 Paris / FR
[N/P]
Former [2017/10]Schlich, George, et al
Schlich
9 St Catherine's Road
Littlehampton, West Sussex BN17 5HS / GB
Application number, filing date16183412.216.02.2006
[2017/10]
Priority number, dateEP2005025101723.02.2005         Original published format: EP 05251017
WO2005GB0316012.08.2005         Original published format: PCT/GB2005/003160
[2017/10]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3138855
Date:08.03.2017
Language:EN
[2017/10]
Search report(s)(Supplementary) European search report - dispatched on:EP02.02.2017
ClassificationIPC:C08B37/00
[2017/10]
CPC:
C07H15/26 (EP,US); A61K47/61 (US); A61K38/27 (EP,US);
C07H5/06 (EP,US); C07K17/10 (US); C08B37/0006 (EP,US);
C08H1/02 (EP,US); C12N9/96 (EP,US); C12P19/44 (US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2017/42]
Former [2017/10]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:AKTIVIERTE SIALINSÄUREDERIVATE FÜR DIE DERIVATISIERUNG UND KONJUGATION VON PROTEINEN[2017/10]
English:ACTIVATED SIALIC ACID DERIVATIVES FOR PROTEIN DERIVATISATION AND CONJUGATION[2017/10]
French:DÉRIVÉS D'ACIDE SIALIQUE ACTIVÉS POUR UNE DÉRIVATION ET CONJUGAISON[2017/10]
Biological materialThis application mentions deposited biological material, check the file for details
Examination procedure09.08.2016Date on which the examining division has become responsible
08.09.2017Amendment by applicant (claims and/or description)
08.09.2017Examination requested  [2017/42]
18.03.2019Communication of intention to grant the patent
30.07.2019Application deemed to be withdrawn, date of legal effect  [2020/04]
03.09.2019Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2020/04]
Parent application(s)   TooltipEP06709777.4  / EP1853634
Fees paidRenewal fee
06.12.2016Renewal fee patent year 03
06.12.2016Renewal fee patent year 04
06.12.2016Renewal fee patent year 05
06.12.2016Renewal fee patent year 06
06.12.2016Renewal fee patent year 07
06.12.2016Renewal fee patent year 08
06.12.2016Renewal fee patent year 09
06.12.2016Renewal fee patent year 10
06.12.2016Renewal fee patent year 11
17.02.2017Renewal fee patent year 12
26.02.2018Renewal fee patent year 13
27.02.2019Renewal fee patent year 14
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]US4225487  (CUATRECASAS PEDRO, et al) [A] 1-12 * column 9, lines 17-23,47-55 *;
 [A]EP0273388  (KANTO ISHI PHARMA CO LTD [JP]) [A] 1-12 * example 16 *;
 [A]EP0371495  (KANTO ISHI PHARMA CO LTD [JP]) [A] 1-12 * example 10 *;
 [A]US5534259  (ZALIPSKY SAMUEL [US], et al) [A] 1-12 * figure 7 * * column 6, line 64 - column 7, line 3 *;
 [A]US6680054  (REECE PHILLIP A [AU], et al) [A] 1-12 * example 12 *;
 [AP]WO2005016973  (LIPOXEN TECHNOLOGIES LTD [GB], et al) [AP] 1-12 * example 3 *;
 [E]WO2006016168  (LIPOXEN TECHNOLOGIES LTD [GB], et al) [E] 1-12* the whole document *;
 [A]  - FAN G-T ET AL, "Stereoselective Synthesis of Neu5Acalpha(2->5)Neu5Gc:The Building Block ofO ligo/Poly(->5-Oglycoly1Neu5Gcalpha2->) Chains in Sea Urchin Egg Cell Surface Glycoprotein", JOURNAL OF ORGANIC CHEMISTRY, AMERICAN CHEMICAL SOCIETY. EASTON, US, (2002), vol. 67, ISSN 0022-3263, pages 7565 - 7568, XP002327875 [A] 1-12 * figure 2 *

DOI:   http://dx.doi.org/10.1021/jo025988p
 [A]  - SOFIA M J, "CARBOHYDRATE-BASED COMBINATORIAL LIBRARIES", MOLECULAR DIVERSITY, ESCOM SCIENCE PUBLISHERS, LEIDEN, NL, (1998), vol. 3, ISSN 1381-1991, pages 75 - 94, XP002914140 [A] 1-12 * pages 85,86; figures 11,12 *

DOI:   http://dx.doi.org/10.1023/A:1009650424835
by applicantUS4356170
 EP0454898
 US5846951
 WO0187922
 WO2005016973
    - BENDELE, A.; SEELY, J.; RICHEY, C.; SENNELLO, G.; SHOPP, G., "Renal tubular vacuolation in animals treated with polyethylene-glycol conjugated proteins", TOXICOLOGICAL SCIENCES, (1998), vol. 42, pages 152 - 157
    - BERANOVA, M.; WASSERBAUER, R.; VANCUROVA, D.; STIFTER, M.; OCENASKOVA, J.; MORA, M., BIOMATERIALS, (2000), vol. 11, pages 521 - 524
    - BROCCHINI, S., "Polymers in medicine: a game of chess", DRUG DISCOVERY TODAY, (2003), vol. 8, pages 111 - 112
    - CARLSSON, J.; DREVIN, H.; AXEN, R., BIOCHEM JOURNAL, (1978), vol. 173, pages 723 - 737
    - CHENG T; WU, M.; WU,P.; CHERN, J; ROFFER, SR., "Accelerated clearance of polyethylene glycol modified proteins by anti-polyethylene glycol IgM", BIOCONJUGATE CHEMISTRY, (1999), vol. 10, pages 520 - 528
    - CHO, J.W.; TROY, F. A., "PSA engineering: Synthesis of polysialylated neoglycosphingolipid by using the polytransferase from neuroinvasive E.coli K1", PROCEEDINGS OF NATIONAL ACADEMIC SCIENCES, USA, (1994), vol. 91, pages 11427 - 11431
    - CONVERS, C. D.; LEJEUNE, L.; SHUM, K.; GILBERT, C.; SHORR, R.G.L, "Physiological effect of polyethylene glycol conjugation on stroma-free bovine hemoglobin in the conscious dog after partial exchange transfusion", ARTIFICIAL ORGAN, (1997), vol. 21, pages 369 - 378
    - DYER, J.R., "Use of periodate oxidation in biochemical analysis", METHODS OF BIOCHEMICAL ANALYSIS, (1956), vol. 3, pages 111 - 152
    - FERNANDES, A.I.; GREGORIADIS, G., "Polysialylated asparaginase: preparation, activity and pharmacokinetics", BIOCHIMICA ET BIOPHYSICA ACTA, (1997), vol. 1341, pages 26 - 34
    - FERNANDES, A.I., "Gregoriadis, G., Synthesis, characterization and properties of polysialylated catalase", BIOCHIMICA ET BIOPHYSICA ACTA, (1996), vol. 1293, pages 92 - 96
    - FERNANDES, A.I.; GREGORIADIS, G., "The effect of polysialylation on the immunogenicity and antigenicity of asparaginase: implications in its pharmacokinetics", INTERNATIONAL JOURNAL OF PHARMACEUTICS, (2001), vol. 217, pages 215 - 224
    - FLEURY, P.; LANGE, J., "Sur I'oxydation des acides alcools et des sucres par I'acid periodique", COMPTES RENDUS ACADEMIC SCIENCES, (1932), vol. 195, pages 1395 - 1397
    - FURUHATA, TRENDS IN GLYCOSCI. GLYCOTECH., (2004), vol. 18, no. 89, pages 143 - 169
    - "Drug and vaccine delivery systems", GREGORIADIS, G., PharmaTech, WORLD MARKETS RESEARCH CENTRE LIMITED, (2001), pages 172 - 176
    - "Polysialic acids: Potential for long circulating drug, protein, liposome and other microparticle constructs", GREGORIADIS, G.; FERNANDES, A.; MCCORMACK, B.; MITAL, M.; ZHANG, X, Targeting of Drugs, Stealth Therapeutic Systems, PLENUM PRESS, (1998), pages 193 - 205
    - GREGORIADIS, G.; FERNANDES, A.; MITAL, M.; MCCORMACK, B., "Polysialic acids: potential in improving the stability and pharmacokinetics of proteins and other therapeutics", CELLULAR AND MOLECULAR LIFE SCIENCES, (2000), vol. 57, pages 1964 - 1969
    - GREGORIADIS, G.; MCCORMACK, B.; WANG, Z.; LIFELY, R., "Polysialic acids: potential in drug delivery", FEBS LETTERS, (1993), vol. 315, pages 271 - 276
    - HRECZUK-HIRST, D.; JAIN, S.; GENKIN, D.; LAING, P.; GREGORIADIS, G., "Preparation and properties of polysialylated interferon-a-2b", AAPS ANNUAL MEETING, (2002), page M1056
    - HUNTER, A. C; MOGHIMI, S. M., "Therapeutic synthetic polymers: a game of Russian Roulette", DRUG DISCOVERY TODAY, (2002), vol. 7, pages 998 - 1001
    - JAIN, S.; HIRST, D. H.; MCCORMACK, B.; MITAL, M.; EPENETOS, A.; LAING, P.; GREGORIADIS, G., "Polysialylated insulin: synthesis, characterization and biological activity in vivo", BIOCHEMICA ET. BIOPHYSICA ACTA, (2003), vol. 1622, pages 42 - 49
    - JAIN, S.; HIRST, D.H.; LAING, P.; GREGORIADIS, G., "Polysialylation: The natural way to improve the stability and pharmacokinetics of protein and peptide drugs", DRUG DELIVERY SYSTEMS AND SCIENCES, (2004), vol. 4, no. 2, pages 3 - 9
    - JENNINGS, H. J.; LUGOWSKI, C., "Immunogenicity of groups A, B, and C meningococal polysaccharide tetanus toxoid conjugates", JOURNAL OF IMMUNOLOGY, (1981), vol. 127, pages 1011 - 1018
    - JENNINGS, H. J. ET AL., J. IMMUNOL., (1986), vol. 137, pages 1708 - 1713
    - LIFELY, R.; GILHERT, A.S.; MORENO, C.C., "Sialic acid polysaccharide antigen of Neisseria meningitidis and Escherichia coli: esterification between adjacent residues", CARBOHYDRATE RESEARCH, (1981), vol. 94, pages 193 - 203
    - MUFLENHOFF, M.; ECTEHARDT , M.; GERARDY-SCHOHN, R., "Polysialic acid: three-dimensional structure, biosynthesis and function", CURRENT OPINIONS IN STRUCTURAL BIOLOGY, (1998), vol. 8, pages 558 - 564
    - PARK, J.T.; JOHNSON, M.J., "A submicrodetermination of glucose", JOURNAL OF BIOLOGICAL CHEMISTRY, (1949), vol. 181, pages 149 - 151
    - PAWLOWSKI, A. ET AL., VACCINE, (1999), vol. 17, pages 1474 - 1483
    - "Polysialic acid as regulator of cell interactions", RUTISHAUSER, U., Neurobiology of Glycoconjugates, PLENUM PRESS, (1989), pages 367 - 382
    - SATAKE, K., J. BIOCHEM., (1960), vol. 47, page 654
    - SVENNERHOLM, L., "Quantitative estimation of sialic acid II: A colorimetric resorcinol-hydrochloric acid method", BIOCHIMCA ET BIOPHYSICA ACTA, (1957), vol. 24, pages 604 - 611
    - TROY, F. A., "Polysialylation of neural cell adhesion molecules", TRENDS IN GLYCOSCIENCE AND GLYCOTECHNOLOGY, (1990), vol. 2, pages 430 - 449
    - TROY, F.A., "Polysialylation: From bacteria to brain", GLYCOBIOLOGY, (1992), vol. 2, pages 1 - 23
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.